Stockscreener 앱 받기
0.00
100.00%
-1.19
시간 외 거래:
1.00
1.00
+
전일 마감가:
$1.19
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$N/A
수익:
$662.00K
순이익/손실:
$-29.02M
주가수익비율:
0.00
EPS:
-8.5
순현금흐름:
$-12.54M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-76.19%
1년 성능:
-86.10%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$1.19
Orgenesis Inc Stock (ORGS) Company Profile
ORGS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORGS
Orgenesis Inc
|
0.00 | 0 | 662.00K | -29.02M | -12.54M | -8.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
419.10 | 106.87B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
491.22 | 63.14B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.77 | 61.27B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
849.46 | 51.94B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
167.91 | 35.04B | 398.11M | -1.03B | -868.57M | -5.7032 |
Orgenesis Inc Stock (ORGS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2018-12-20 | 개시 | Dawson James | Buy |
Orgenesis Inc 주식(ORGS)의 최신 뉴스
Why Orgenesis Inc. (45O) stock remains top rated2025 Investor Takeaways & Expert Approved Momentum Ideas - newser.com
In-Depth 2025 Common Warts Industry Forecast: Plan Your Strategy for 2034 Success - WhaTech
Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts Market: Pushing the Bounda... - WhaTech
Will Orgenesis Inc. (45O) stock benefit from infrastructure billJuly 2025 Patterns & Daily Technical Stock Forecast Reports - newser.com
Can Orgenesis Inc. (45O) stock withstand sector downturnsJuly 2025 Summary & Free Long-Term Investment Growth Plans - newser.com
Orgenesis Presents Technology Update To FDA/CBER Experts - AOL.com
Is Orgenesis Inc 45O a good long term investmentFibonacci Retracement Levels & Explosive Trading Portfolio - earlytimes.in
Is Orgenesis Inc. (45O) stock a top pick for value investorsTrade Exit Report & Low Drawdown Trading Strategies - newser.com
Why Institutions Believe Beeyu Overseas Limited Is Undervalued TodayStock Buyback Updates & High Profit Market Tips - earlytimes.in
Orgenesis (NASDAQ:ORGS) and Oragenics (NYSE:OGEN) Critical Contrast - Defense World
Orgenesis Faces Multiple Leadership Resignations in August - MSN
Orgenesis subsidiary Theracell enters $1 million convertible loan agreement By Investing.com - Investing.com South Africa
Orgenesis subsidiary Theracell enters $1 million convertible loan agreement - Investing.com India
Orgenesis Subsidiary Secures Convertible Loan Agreement - TipRanks
Riku Dining Group Ltd sees U.S. IPO of 2.3 million Class A ordinary shares - MarketScreener
LB Pharmaceuticals raises $285 million in US IPO - MarketScreener
Genital Warts Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential - Barchart.com
Exclusive-Stablecoin issuer Figure Technologies set to upsize IPO as demand for crypto-related stocks soars, source says - MarketScreener
Orgenesis’s Sharp Swings Define Its High-Risk Biotech Story - Finimize
Orgenesis Inc (ORGS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.03%
2.67%
자본화:
|
볼륨(24시간):